Results 151 to 160 of about 6,940,670 (314)

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity

Molecular Oncology, EarlyView.
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek, Jenny Sprooten, Abhishek D. Garg   +2 more
wiley   +1 more source

Lung cancer.

Cancer chemotherapy and biological response modifiers, 1990
H. Hansen, M. Ro̸rth
semanticscholar   +1 more source

Lactoferrin treatment activates acetylcholinesterase, decreasing acetylcholine levels in non‐small cell lung cancer (NSCLC) cell culture supernatants, inhibiting cell survival

FEBS Open Bio, EarlyView.
Representation of the suggested mode of action of lactoferrin (Lf) in nonsmall cell lung cancer (NSCLC) A549 cells. Lf induces activation of caspase‐3 by activating p53 and AChE leading to decreased ACh concentrations. In turn, ACh signaling leads to activation of VEGF and AKT and blocking of caspase‐3.
Stuti Goel, Caroline Wozniak, Aya Sabri, Ben Haddad, Brooke Lopo, Alvaro Cobos, Sarah Sarofim, Jeffrey Guthrie, Deborah Heyl, Hedeel Guy Evans   +9 more
wiley   +1 more source

Ferroptosis and Radiotherapy in Lung Cancer. [PDF]

Cells
Patel PC, Galvan EM.
europepmc   +1 more source

Pentapeptides for the treatment of small cell lung cancer: Optimisation by N ind -alkyl modification of the tryptophan side chain

, 2017
Osama H. Abusara, Sally Freeman, Harmesh Aojula   +2 more
openalex   +1 more source

Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer [PDF]

, 2018
Yanwu Zhou, Rong Li, Chaojun Duan, Yang Gao, Yuanda Cheng, Chunfang Zhang   +5 more
openalex   +1 more source

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

New England Journal of Medicine, 2006
A. Sandler, R. Gray, M. Perry, J. Brahmer, J. Schiller, A. Dowlati, R. Lilenbaum, David H. Johnson   +7 more
semanticscholar   +1 more source

Indoleamine 2,3‐dioxygenase 1 inhibition reverses cancer‐associated fibroblast‐mediated immunosuppression in high‐grade serous ovarian cancer

FEBS Open Bio, EarlyView.
CAF‐mediated immunosuppression in ovarian cancer is driven by IDO1, reducing T‐cell function. Inhibiting IDO1 restores T‐cell proliferation and cytotoxicity, increases cancer cell apoptosis, and may help overcome CAF‐induced immune suppression in high‐grade serous ovarian cancer. Targeting IDO1 may improve antitumor immunity.
Hyewon Lee, Jung Yoon Ho, In Sun Hwang, Youn Jin Choi   +3 more
wiley   +1 more source

Pulmonary Tuberculosis: The Great Mimicker of Lung Cancer. [PDF]

Clin Case Rep
Corrales-Diaz Pomatto-Watson L, Johl HS, Meiklejohn K.   +2 more
europepmc   +1 more source

Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: impact on negative-misclassifications and clinical referral rate [PDF]

A. Walstra, Harriet L Lancaster, Marjolein A. Heuvelmans, Carlijn M. van der Aalst, J Hubert, Dana Moldovanu, Sytse F. Oudkerk, Daiwei Han, Jan W. Gratama, Mario Silva, Harry J. de Koning, Matthijs Oudkerk   +11 more
openalex   +1 more source